Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against agilon health, inc. (NYSE: AGL) and certain officers, alleging violations of federal securities laws. The lawsuit claims that the company issued misleading guidance for 2026 and overstated the positive financial impact of strategic actions, leading to investor harm for those who purchased securities between February 26, 2025, and August 4, 2025. Investors are encouraged to join the case, with a lead plaintiff deadline of March 2, 2026.
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against agilon health, inc. (NYSE: AGL) and certain officers, alleging federal securities law violations. The lawsuit claims that agilon health made false or misleading statements regarding its 2026 guidance and the financial impact of its "strategic actions," harming investors who purchased securities between February 26, 2025, and August 4, 2025. Investors are encouraged to join the case, with a lead plaintiff deadline of March 2, 2026.
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against agilon health, inc. (NYSE: AGL) and its officers, alleging violations of federal securities laws. The lawsuit claims that the company issued misleading guidance for 2026, overstated the financial impact of "strategic actions," and made materially false statements regarding its business and prospects. Investors who purchased agilon securities between February 26, 2025, and August 4, 2025, are encouraged to join the case by March 2, 2026, to potentially recover damages.
AGL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026
Faruqi & Faruqi, LLP is reminding investors of the upcoming March 2, 2026 deadline to seek lead plaintiff status in a securities class action against agilon health (NYSE: AGL). The lawsuit alleges that agilon health and its executives made false and misleading statements regarding the company's 2025 guidance and the impact of "strategic actions," failing to disclose material industry headwinds. Investors who suffered losses exceeding $50,000 between February 26, 2025, and August 4, 2025, are encouraged to contact the law firm to discuss their legal options.
Notice of Securities Fraud Lawsuit Against Agilon Health, Inc.
A class action lawsuit has been filed against Agilon Health, Inc. (AGL) on behalf of investors who purchased securities between February 26, 2025, and August 4, 2025. The lawsuit alleges that the company issued unrealistic 2025 financial guidance amid known industry headwinds, leading to significant investor losses. Investors are encouraged to apply by March 2, 2026, to become lead plaintiffs in the lawsuit.
AGL DEADLINE NOTICE: agilon health, inc. Investors Encouraged to Contact Kirby McInerney LLP By March 2, 2026
Kirby McInerney LLP is encouraging investors of agilon health, inc. (NYSE: AGL) who suffered losses to contact them by March 2, 2026, to discuss their rights in a securities fraud class action lawsuit. The lawsuit alleges that agilon made misleading statements and failed to disclose critical industry headwinds, leading to a significant drop in its stock price after suspending its 2025 financial guidance. Investors have the opportunity to apply to be appointed as lead plaintiff in the case.
AGL DEADLINE NOTICE: agilon health, inc. Investors Encouraged to Contact Kirby McInerney LLP By March 2, 2026
Kirby McInerney LLP is encouraging investors of agilon health, inc. (NYSE: AGL) who suffered losses to contact them by March 2, 2026, regarding a securities fraud class action lawsuit. The lawsuit alleges that agilon made misleading statements about its 2025 guidance and the financial impact of its "strategic actions," leading to a significant stock price drop after the company suspended its financial guidance and announced a leadership change. Investors can contact Lauren Molinaro for more information or to discuss their rights.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - AGL
Pomerantz LLP has announced a class action lawsuit against agilon health, inc. (NYSE: AGL) for alleged securities fraud, advising investors who suffered losses to contact them. The class action deadline for investors to seek appointment as Lead Plaintiff is March 2, 2026. This action follows a significant drop in Agilon's stock price after the company suspended its full-year 2025 financial guidance and announced a CEO change due to unexpected industry headwinds.
AGILON HEALTH, INC. (NYSE: AGL) SHAREHOLDER ALERT Bernstein
Bernstein Liebhard LLP is reminding investors of agilon health, inc. (NYSE: AGL) about an upcoming deadline of March 2, 2026, for a securities fraud class action lawsuit. The lawsuit alleges that the company and its senior officers made misrepresentations concerning their 2025 guidance to investors who purchased shares between February 26, 2025, and August 4, 2025. Investors who lost money are encouraged to contact Bernstein Liebhard LLP to discuss their legal options or to serve as lead plaintiff.
Reverse split proposal highlights NYSE bid risk for agilon health (AGL)
agilon health (AGL) is proposing a reverse stock split at a ratio between 1-for-5 and 1-for-25 to address its share price falling below the NYSE's minimum bid requirement of $1.00. The company received a non-compliance notice on November 5, 2025, and believes the split could help it regain compliance and improve marketability to institutional investors. While the board recommends approval, it acknowledges risks such as negative investor perception and no guarantee of sustained price increase or restored liquidity.
Agilon Health shares plunge after Q2 miss, leadership shakeup, and suspended guidance
Agilon Health (AGL) experienced a significant drop in its share price after announcing a Q2 earnings and revenue miss, a change in its leadership, and the suspension of its full-year guidance. The company reported a net loss per share of $0.09 and revenue of $426 million, both falling short of analyst expectations. CEO Steve Sell will step down, to be replaced by the current COO, Veena Doan, while the company focuses on improving profitability and operations.
Deadline Alert: agilon health, inc. (AGL) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP is urging shareholders of agilon health, inc. (AGL) who suffered losses between February 26, 2025, and August 4, 2025, to contact them regarding a securities fraud class action lawsuit. The lawsuit alleges that agilon issued misleading guidance for 2025 and overstated the positive financial impact of strategic actions, leading to a significant stock price drop after the CEO's departure and missed financial estimates. Investors have until March 2, 2026, to file a lead plaintiff motion.
Class Action Filed Against agilon health, inc. (AGL) - March 2, 2026 Deadline to Join - Contact Levi & Korsinsky
A securities class action lawsuit has been filed against agilon health, inc. (NYSE: AGL) on behalf of investors who suffered losses between February 26, 2025, and August 4, 2025. The complaint alleges that the company issued unreachable 2025 guidance and overstated the financial benefits of strategic risk-reduction actions, leading to misleading statements about its business prospects.
Class Action Filed Against agilon health, inc. (AGL) - March 2, 2026 Deadline to Join - Contact Levi & Korsinsky
A class action securities lawsuit has been filed against agilon health, inc. (AGL) on behalf of investors who suffered losses between February 26, 2025, and August 4, 2025. The lawsuit alleges that the company's guidance for 2025 and statements about the positive financial impact of "strategic actions" were false and misleading. Investors have until March 2, 2026, to request to be appointed as lead plaintiff.
Agilon Health, Inc. $AGL Shares Acquired by CenterBook Partners LP
CenterBook Partners LP significantly increased its stake in Agilon Health (NYSE:AGL) by 492.4% in the third quarter, acquiring over 9.4 million additional shares, reflecting a total holding of 11.4 million shares valued at approximately $11.77 million. Despite this increased institutional interest, Agilon Health faces multiple class-action lawsuits alleging securities fraud, creating a material legal overhang. The stock is currently trading around its 1-year low, and while analysts have a consensus "Hold" rating with an average target price of $2.71, several firms have recently reduced their price targets to $1.00.
Class Action Filed Against agilon health, inc. (AGL) - March 2, 2026 Deadline to Join - Contact Levi & Korsinsky
Levi & Korsinsky, LLP has filed a class action securities lawsuit against agilon health, inc. (AGL) alleging that the company made false statements and/or concealed material industry headwinds and overstated the financial impact of strategic actions. Investors who suffered losses between February 26, 2025, and August 4, 2025, have until March 2, 2026, to request to be appointed as lead plaintiff. The firm is offering representation with no out-of-pocket costs or fees for class members.
AGILON HEALTH, INC. (NYSE:AGL) DEADLINE ALERT Bernstein Liebhard LLP Reminds agilon health, inc. Investors of Upcoming Deadline
Bernstein Liebhard LLP is alerting investors of agilon health, inc. (NYSE:AGL) about an upcoming deadline for a securities fraud class action lawsuit. The lawsuit targets misrepresentations regarding the Company's 2025 guidance. Investors who purchased Agilon shares between February 26, 2025, and August 4, 2025, and suffered losses are encouraged to contact the firm by March 2, 2026, to discuss their legal rights and potentially serve as a lead plaintiff.
Bragar Eagel & Squire, P.C. Reminds Agilon Health, Inc.
Bragar Eagel & Squire, P.C. reminds Agilon Health, Inc. investors with significant losses of the upcoming March 2nd lead plaintiff deadline for a class action lawsuit. The lawsuit alleges that Agilon made false and misleading statements regarding its 2025 guidance and the positive financial impact of its "strategic actions." Investors who purchased Agilon securities between February 26, 2025, and August 4, 2025, are urged to contact the firm to discuss their legal rights.
How to hear agilon health's March conference talks live
Agilon health (NYSE: AGL) announced its management team will participate in three healthcare conferences in March 2026: the 46th Annual Cowen Health Care Conference, the Jefferies Healthcare Services Innovation & Technology Summit, and the 28th Annual Barclays Global Healthcare Conference. Live webcasts will be available for the Cowen and Barclays conferences on the company's investor relations website, while the Jefferies event will not have a webcast. Interested investors can access replays and simultaneous webcasts via the company's "Events & Presentations" section.
agilon health to Participate in Upcoming Conferences
agilon health announced its management team will attend three upcoming healthcare conferences in March 2026: the 46th Annual Cowen Health Care Conference, the Jefferies Healthcare Services Innovation & Technology Summit, and the 28th Annual Barclays Global Healthcare Conference. Webcasts will be available for two of the events on the company’s investor relations website. The announcement also reiterated agilon health's mission to empower physicians in transforming healthcare for senior patients through a value-based Total Care Model.
agilon health, inc. (AGL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announced that investors who lost money in agilon health, inc. (AGL) have the opportunity to lead a securities fraud class action lawsuit. The lawsuit alleges that the company's guidance for 2025 was recklessly issued and that positive statements about its business were misleading due to undisclosed industry headwinds and overstated financial impacts from strategic actions. Investors who suffered losses between February 26, 2025, and August 4, 2025, are encouraged to contact the firm before the lead plaintiff deadline of March 2, 2026.
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against agilon health, inc. (NYSE: AGL) and certain officers, alleging federal securities law violations. The lawsuit claims that during the Class Period (February 26, 2025, to August 4, 2025), agilon health made false or misleading statements regarding its 2026 guidance and the financial impact of strategic actions. Investors who acquired agilon securities during this period are encouraged to join the case, with a lead plaintiff deadline of March 2, 2026.
Robbins LLP Urges AGL Stockholders with Large Losses to Contact the Firm for Information About Leading the Agilon Health, Inc. Securities Class Action
Robbins LLP is calling on stockholders of Agilon Health, Inc. (NYSE: AGL) who experienced significant losses to join a class action lawsuit. The lawsuit alleges that Agilon Health misled investors by issuing unrealistic financial guidance for 2025 and overstating the impact of its "strategic actions," which led to a more than 50% stock price drop after disappointing Q3 2025 financial results and the CEO's departure. Shareholders have until March 2, 2026, to file as lead plaintiff.
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm has announced a class action lawsuit against agilon health, inc. (NYSE: AGL) for alleged securities fraud during the Class Period of February 26, 2025, to August 4, 2025. The firm encourages investors who suffered losses to contact them before March 2, 2026. The lawsuit claims Agilon made false and misleading statements regarding its 2026 guidance and the impact of its strategic actions.
AGILON DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to ...
The Rosen Law Firm is reminding investors of agilon health, inc. (NYSE: AGL) who purchased securities between February 26, 2025, and August 4, 2025, about the approaching lead plaintiff deadline of March 2, 2026, in a securities class action lawsuit. The lawsuit alleges that agilon health, inc. made false or misleading statements regarding its 2023 guidance, the positive financial impact of its "strategic actions," and the overall state of its business and prospects. Investors who suffered damages are encouraged to join the class action to potentially seek compensation.
Agilon Health Deadline: AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm
The Rosen Law Firm is reminding investors who purchased agilon health, inc. (NYSE: AGL) securities between February 26, 2025, and August 4, 2025, that they have an opportunity to serve as lead plaintiff in a securities class action lawsuit. The deadline to move the Court for lead plaintiff status is March 2, 2026. The lawsuit alleges that defendants issued misleading guidance for 2025 and materially overstated the financial impact of strategic actions, causing investor damages.
Agilon Health Shareholders Sue Company Over Guidance Statements
Agilon Health (AGL) is facing a class action lawsuit filed on December 31, 2025, by shareholders who allege they purchased stock at artificially inflated prices between February 26, 2025, and August 4, 2025. The lawsuit claims Agilon and two senior officers intentionally misled investors by omitting crucial information about its 2025 guidance and business practices. The alleged misconduct was revealed through events on August 4, 2025, including executive departures and statements acknowledging unexpected industry headwinds and underperformance.
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm has announced a class action lawsuit against agilon health, inc. (NYSE: AGL) for alleged securities fraud, encouraging investors who purchased securities between February 26, 2025, and August 4, 2025, to contact the firm by March 2, 2026. The lawsuit claims Agilon made false and misleading statements about its 2026 guidance and the impact of its risk reduction strategies, leading to investor damages. Shareholders are invited to join the case to recover their losses.
AGILON HEALTH, INC. (NYSE: AGL) SHAREHOLDER ALERT Bernstein
Bernstein Liebhard LLP reminds investors of an upcoming deadline for an agilon health, inc. (NYSE: AGL) securities fraud class action lawsuit. Investors who purchased Agilon shares between February 26, 2025, and August 4, 2025, and suffered losses are encouraged to contact the firm by March 2, 2026, to discuss their legal options or potentially serve as lead plaintiff. The lawsuit alleges misrepresentations regarding the company's 2025 guidance.
AGL LAWSUIT ALERT: The Gross Law Firm Notifies agilon health, inc. Investors of a Class Action Lawsuit and Upcoming Deadline
The Gross Law Firm has announced a class action lawsuit against agilon health, inc. (NYSE: AGL), encouraging shareholders who purchased shares between February 26, 2025, and August 4, 2025, to contact them. The lawsuit alleges that agilon health issued misleading guidance for 2025 and overstated the financial impact of strategic actions. The deadline for shareholders to seek lead plaintiff appointment is March 2, 2026.
Agilon Health Amends Credit Agreement, Extends Debt Maturity
Agilon Health recently amended its credit agreement, extending the maturity date of its term loans to February 18, 2028, and revising key financial covenants. These changes include tightening liquidity discipline through new cash, collateral, and leverage requirements, which should strengthen the company's capital structure. TipRanks’ AI Analyst, Spark, rates AGL as Neutral due to weak financial performance and elevated corporate-event risk despite the extended debt maturity.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 2, 2026 in agilon health, inc. Lawsuit – AGL
Levi & Korsinsky, LLP is reminding shareholders of agilon health, inc. (NYSE: AGL) about a class action securities lawsuit. The lawsuit alleges that agilon health, inc. made false statements and/or concealed information regarding its 2025 guidance and the financial impact of its strategic actions. Investors who suffered losses between February 26, 2025, and August 4, 2025, have until March 2, 2026, to request to be appointed as lead plaintiff.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - AGL
Pomerantz LLP has announced a class action lawsuit against agilon health, inc. (AGL) for alleged securities fraud, advising investors who suffered losses to contact them by March 2, 2026, to apply for lead plaintiff. The lawsuit stems from Agilon's August 4, 2025 announcement of its CEO's departure, suspension of 2025 financial guidance, and significant stock price drop following unexpected industry headwinds.
AGILON HEALTH, INC. (NYSE: AGL) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds agilon health, ...
Bernstein Liebhard LLP has issued a shareholder alert regarding a securities fraud class action lawsuit against agilon health, inc. (NYSE: AGL). The lawsuit, filed on behalf of investors who purchased shares between February 26, 2023, and August 3, 2023, alleges violations of the Securities Exchange Act of 1934 due to misrepresentations concerning the company's 2023 guidance. Investors are encouraged to contact the firm if they experienced losses, with a lead plaintiff deadline of March 2, 2026.
AGILON HEALTH, INC. (NYSE: AGL) SHAREHOLDER ALERT Bernstein
Bernstein Liebhard LLP has issued a shareholder alert for investors of agilon health, inc. (NYSE: AGL) regarding an upcoming class action lawsuit. The lawsuit alleges securities fraud, with misrepresentations concerning the company's 2025 guidance. Investors who purchased shares between February 26, 2025, and August 4, 2025, are encouraged to contact the firm by March 2, 2026, to discuss their legal rights and options.
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm has reminded investors of a class action lawsuit against agilon health, inc. (NYSE: AGL) for alleged securities fraud. The lawsuit claims that Agilon made false and misleading statements about its 2026 guidance and the impact of its "strategic actions" to reduce risk. Investors who purchased the company's securities between February 26, 2025, and August 4, 2025, are encouraged to contact the firm by March 2, 2026.
AGL LAWSUIT ALERT: The Gross Law Firm Notifies agilon health, inc. Investors of a Class Action Lawsuit and Upcoming Deadline
The Gross Law Firm has issued a notice to investors of agilon health, inc. (NYSE: AGL) regarding a class action lawsuit. The lawsuit alleges that defendants made false and misleading statements about the company's financial guidance and the positive impact of strategic actions, leading to inflated stock prices. Shareholders who purchased shares between February 26, 2025, and August 4, 2025, are encouraged to contact the firm by the March 2, 2026 deadline to potentially be appointed as lead plaintiff.
AGL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026
Faruqi & Faruqi, LLP reminds agilon health (AGL) investors of the upcoming March 2, 2026 deadline to seek lead plaintiff status in a federal securities class action lawsuit. The lawsuit alleges that agilon health and its executives made false and misleading statements regarding the company's financial guidance and the impact of "strategic actions," leading to a significant stock drop when the true details emerged. Investors who purchased AGL securities between February 26, 2025, and August 4, 2025, are encouraged to contact the firm to discuss their legal options.
The Gross Law Firm Notifies agilon health, inc. Investors of a Class Action Lawsuit and ...
The Gross Law Firm has issued a notice to shareholders of agilon health, inc. (NYSE: AGL) regarding a class action lawsuit. The lawsuit alleges that the company made materially false and misleading statements and/or failed to disclose crucial information during the period of February 2, 2023, to August 4, 2023. Investors who purchased AGL shares during this period are encouraged to contact the firm by March 2, 2026, to discuss lead plaintiff appointment.
The Gross Law Firm Notifies agilon health, inc. Investors of a Class Action Lawsuit and Upcoming Deadline – AGL
The Gross Law Firm has issued a notice to agilon health, inc. (NYSE: AGL) shareholders regarding a class action lawsuit. Investors who purchased shares between February 26, 2025, and August 4, 2025, are encouraged to contact the firm to potentially be appointed as lead plaintiff. The lawsuit alleges that agilon health made materially false and misleading statements concerning its 2025 guidance and the financial impact of its strategic actions.
agilon health, inc. (AGL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP has announced a securities fraud class action lawsuit against agilon health, inc. (AGL) for investors who suffered losses. The lawsuit alleges that agilon health issued misleading guidance for 2025 and overstated the positive financial impact of its strategic actions, leading investors to believe the company's prospects were better than they truly were. Investors who suffered losses between February 26, 2025, and August 4, 2025, have until March 2, 2026, to participate as lead plaintiffs.
AGL DEADLINE NOTICE: agilon health, inc. Investors Encouraged to Contact Kirby McInerney LLP By March 2, 2026
Kirby McInerney LLP is encouraging investors who suffered losses in agilon health, inc. (NYSE: AGL) to contact them regarding a securities fraud class action lawsuit. The deadline for investors to apply to be appointed as lead plaintiff is March 2, 2026. The lawsuit alleges that agilon made false statements and failed to disclose information regarding its 2025 guidance and the impact of its strategic actions, leading to a significant drop in stock price after the company suspended its guidance.
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against agilon health, inc. (NYSE: AGL) and its officers, alleging violations of federal securities laws. The lawsuit claims that agilon health issued misleading guidance for 2026 and overstated the financial impact of its strategic actions, causing investor harm during the Class Period from February 26, 2025, to August 4, 2025. Investors who suffered losses are encouraged to join the case by March 2, 2026, with the firm offering contingency-based representation.
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A
Bernstein Liebhard LLP has announced a securities class action lawsuit against agilon health, inc. (NYSE: AGL) on behalf of investors who purchased shares between February 26, 2025, and August 4, 2025. The lawsuit alleges that Agilon made misrepresentations regarding its 2025 guidance. Shareholders who wish to serve as lead plaintiff must file papers by March 2, 2026.
Deadline Alert: agilon health, inc. (AGL) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP is urging shareholders of agilon health, inc. (AGL) who suffered losses to contact them regarding an upcoming March 2, 2026, deadline to file a lead plaintiff motion in a securities fraud class action lawsuit. The lawsuit alleges that agilon health made materially false and misleading statements and failed to disclose adverse facts, particularly concerning its 2025 guidance and the impact of "strategic actions," leading to a significant stock price drop after the CEO's departure and missed Q2 2025 financial results.
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against agilon health, inc. (NYSE: AGL)
Bernstein Liebhard LLP has filed a securities fraud class action lawsuit against agilon health, inc. (NYSE: AGL) on behalf of investors who purchased securities between February 26, 2025, and August 4, 2025. The lawsuit alleges that the company made misrepresentations concerning its 2025 guidance. Shareholders who lost money during this period are encouraged to contact the firm to discuss their legal options or to serve as lead plaintiff by March 2, 2026.
ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL
The Rosen Law Firm is reminding investors in agilon health, inc. (NYSE: AGL) who purchased securities between February 26, 2025, and August 4, 2025, of the March 2, 2026, deadline to serve as lead plaintiff in a securities class action lawsuit. The lawsuit alleges that agilon health made false or misleading statements regarding its 2025 guidance and the financial impact of strategic actions. Investors are encouraged to contact the firm for more information on joining the lawsuit.
ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before ...
Rosen Law Firm is notifying purchasers of agilon health, inc. (NYSE: AGL) securities between February 26, 2025, and August 4, 2025, about an important lead plaintiff deadline of March 2, 2026, in a securities class action lawsuit. The lawsuit alleges that agilon health made false or misleading statements regarding its 2025 guidance and the financial impact of its "strategic actions," causing investors to suffer damages when the true details emerged. The firm advises affected investors to seek qualified legal counsel with a proven track record in leadership roles for securities class actions.
Agilon Health Faces Class Action for Securities Fraud
Agilon Health is facing a class action lawsuit for alleged securities fraud, with investors claiming the company made false and misleading statements about its strategic actions, leading to financial losses. Several law firms are alerting investors to the lawsuit, which concerns securities purchased between February 26, 2025, and August 4, 2025, with a lead plaintiff deadline of March 2, 2026. The allegations highlight significant failures in the company's disclosure practices and overstatements of financial impact.
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is reminding investors of a class action lawsuit against agilon health, inc. (NYSE: AGL) for alleged securities fraud. The lawsuit claims that Agilon made false and misleading statements regarding its 2026 guidance and the impact of its "strategic actions," causing investors to suffer damages. Investors who purchased Agilon securities between February 26, 2025, and August 4, 2025, are encouraged to contact the firm before March 2, 2026, to discuss their rights.
